In the current trading session, Sunshine Biopharma Inc’s (SBFM) stock is trading at the price of $1.57, a gain of 8.28% over last night’s close. So, the stock is trading at a price that is -80.44% less than its 52-week high of $8.03 and 34.27% better than its 52-week low of $1.17. Based on the past 30-day period, the stock price is -14.52% below the high and +11.51% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, SBFM’s SMA-200 is $2.3162.
It is also essential to consider SBFM stock ratios like the price-to-sales ratio, which is 0.20 for the last year.SBFM’s price to book ratio for the most recent quarter was 0.19, resulting in an 0.88 price to cash per share for the period.
How does Sunshine Biopharma Inc (SBFM) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 1 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 5.00 in simple terms.
Sunshine Biopharma Inc (SBFM): Earnings History
In the 3 months period before the previous quarter which was closed on 3/31/2025, the stock recorded adjusted earnings per share of -$0.44 in contrast with the Outlook of -$.
Sunshine Biopharma Inc (NASDAQ: SBFM) Ownership Details
I will give a breakdown of the key shareholders in Sunshine Biopharma Inc (SBFM). Recent figures show that the company’s insiders hold 3.17% of shares. A total of 11 institutional investors hold shares in the company, making 1.74% of its stock and 1.80% of its float.
Mar 31, 2025 , it was reported that the Company’s largest institutional holder is Altium Capital Management, LP holding total of 50.47 shares that make 1.11% of the company’s total number of shares and are currently priced at 77212.0.
The securities firm UBS Group AG holds 19.89 shares of SBFM, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.44% , and the holding percentage of shares is valued at 30424.0.
An overview of Sunshine Biopharma Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Sunshine Biopharma Inc (SBFM) traded 139,961 shares per day, with a moving average of $1.5148 and price change of unch. With the moving average of $1.4468 and a price change of +0.2600, about 160,022 shares changed hands on average over the past 50 days. Finally, SBFM’s 100-day average volume is 942,545 shares, alongside a moving average of $1.7515 and a price change of -1.0700.
